LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 23.10 | 84.90 | 6 | 1616 | 0.0037 | -0.4639 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 23.10 | 84.90 | 1836 | 1616 | 1.1360 | 1.0609 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 24.81 | 84.90 | 1423 | 1769 | 0.8042 | 0.9030 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 24.81 | 84.90 | 1615 | 1769 | 0.9127 | 0.9587 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 24.81 | 84.90 | 7 | 1769 | 0.0040 | -0.4342 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 24.81 | 84.90 | 1967 | 1769 | 1.1116 | 1.0489 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 26.51 | 84.90 | 1521 | 1923 | 0.7909 | 0.8984 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 26.51 | 84.90 | 1696 | 1923 | 0.8819 | 0.9449 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 26.51 | 84.90 | 10 | 1923 | 0.0052 | -0.3782 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 26.51 | 84.90 | 2070 | 1923 | 1.0763 | 1.0330 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 28.21 | 84.90 | 1673 | 2091 | 0.7999 | 0.9057 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 28.21 | 84.90 | 1801 | 2091 | 0.8611 | 0.9363 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 28.21 | 84.90 | 303 | 2091 | 0.1449 | 0.3168 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 28.21 | 84.90 | 2263 | 2091 | 1.0820 | 1.0344 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 29.92 | 84.90 | 1772 | 2237 | 0.7919 | 0.9035 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 29.92 | 84.90 | 1934 | 2237 | 0.8643 | 0.9391 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 29.92 | 84.90 | 1639 | 2237 | 0.7324 | 0.8723 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 29.92 | 84.90 | 2418 | 2237 | 1.0806 | 1.0331 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 31.62 | 84.90 | 1895 | 2449 | 0.7736 | 0.8969 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 31.62 | 84.90 | 2070 | 2449 | 0.8450 | 0.9318 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 31.62 | 84.90 | 2002 | 2449 | 0.8172 | 0.9185 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 31.62 | 84.90 | 2664 | 2449 | 1.0875 | 1.0349 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 33.32 | 84.90 | 1994 | 2722 | 0.7324 | 0.8793 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 33.32 | 84.90 | 2194 | 2722 | 0.8059 | 0.9156 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 33.32 | 84.90 | 2567 | 2722 | 0.9429 | 0.9766 | MN20160318_Q02 | I11 |